|
| 力生制药(002393)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2026-12-30 | 58.55 | 0.23% | 25099.61 | 662.08 | 25101.68 | 97.44% | 股权激励限售股份 | | 2026-12-04 | 11.27 | 0.04% | 25041.06 | 720.63 | 25101.68 | 97.44% | 股权激励限售股份 | | 2025-12-30 | 58.30 | 0.23% | 25101.68 | 660.01 | 25043.73 | 97.21% | 股权激励限售股份 | | 2025-12-05 | 11.27 | 0.04% | 25043.73 | 717.95 | 25032.46 | 97.17% | 股权激励限售股份 | | 2025-01-10 | 68.45 | 0.27% | 25612.15 | 177.39 | 25543.70 | 99.05% | 股权激励限售股份 | | 2013-04-23 | 9824.76 | 53.85% | 18245.50 | 0.00 | 18245.50 | 100.00% | 发行前股份限售流通 | | 2011-04-25 | 3820.74 | 20.94% | 8420.74 | 9824.76 | 18245.50 | 100.00% | 发行前股份限售流通 | | 2010-07-23 | 920.00 | 5.04% | 4600.00 | 13645.50 | 18245.50 | 100.00% | A股发行法人配售上市 |
|